Healthcare

4DMedical (ASX:4DX) attracted renewed market attention after rising 7.56% to AUD 4.625. The shares moved between AUD 4.33 and AUD 4.63, with 4,254,912 units changing hands. The gain placed a fresh spotlight on the company’s latest clinical, regulatory, commercial or corporate development.

Careteq (ASX:CTQ) attracted renewed market attention after rising 18.18% to AUD 0.013. The shares moved between AUD 0.012 and AUD 0.013, with 5,848,949 units changing hands. The gain placed a fresh spotlight on the company’s latest clinical, regulatory, commercial or corporate development.

Neuren Pharmaceuticals (ASX:NEU) attracted renewed market attention after rising 16.04% to AUD 21.595. The shares moved between AUD 19.99 and AUD 22.00, with 1,162,377 units changing hands. The gain placed a fresh spotlight on the company’s latest clinical, regulatory, commercial or corporate development.

AdAlta (ASX:1AD) attracted renewed market attention after rising 14.29% to AUD 0.004. The shares moved between AUD 0.004 and AUD 0.004, with 10,447,006 units changing hands. The gain placed a fresh spotlight on the company’s latest clinical, regulatory, commercial or corporate development.

Clarity Pharmaceuticals (ASX:CU6) attracted renewed market attention after rising 13.29% to AUD 2.855. The shares moved between AUD 2.57 and AUD 2.91, with 2,826,850 units changing hands. The gain placed a fresh spotlight on the company’s latest clinical, regulatory, commercial or corporate development.

ImpediMed (ASX:IPD) attracted renewed market attention after rising 12.50% to AUD 0.005. The shares moved between AUD 0.004 and AUD 0.005, with 364,557 units changing hands. The gain placed a fresh spotlight on the company’s latest clinical, regulatory, commercial or corporate development.

Noxopharm (ASX:NOX) attracted renewed market attention after rising 11.39% to AUD 0.088. The shares moved between AUD 0.088 and AUD 0.088, with 53,434 units changing hands. The gain placed a fresh spotlight on the company’s latest clinical, regulatory, commercial or corporate development.